August 20, 2024
Having an ostomy is a dreaded prospect for many patients with rectal cancer. To defer, and potentially avoid, this life-altering surgery, the watch-and-wait approach has become […]
August 20, 2024
TOPLINE: Neoadjuvant immunotherapy in high-risk patients with hepatocellular carcinoma (HCC) led to similar recurrence-free survival (RFS) and margin-negative resection rates compared with patients undergoing upfront surgery. […]
August 19, 2024
TOPLINE: Stereotactic body radiotherapy (SBRT) is a safe treatment option for patients with oligometastatic cancer, with only 0.5% of patients experiencing severe acute toxicities within 6 […]
August 16, 2024
The US Food and Drug Administration (FDA) has approved durvalumab (Imfinzi; AstraZeneca) both before and after surgery in patients with resectable non–small cell lung cancer (NSCLC) […]
August 16, 2024
TOPLINE: Integrating patient-reported outcome measures (PROMs) into cancer care was associated with improved overall survival and health-related quality-of-life (QoL) in the short-term, though not emergency department […]
August 15, 2024
(Reuters) – Incyte said on Thursday its drug met the main goal in a late-stage trial evaluating it in patients with a form of blood cancer. […]
August 15, 2024
(Reuters) – Bayer won a legal victory in its fight to limit liability from claims its Roundup weed killer causes cancer, as a U.S. appeals court […]
August 15, 2024
TOPLINE: The Breast Cancer Index (BCI) can predict which premenopausal women with hormone receptor–positive breast cancer benefit from ovarian function suppression (OFS) therapy. Women with BCI […]
August 15, 2024
TOPLINE: Women with endometriosis show a higher risk for ovarian cancer, and the magnitude varies with the subtype of endometriosis, with the highest risk seen in […]